Early Mortality After the First Dose of COVID-19 Vaccination: A Target Trial Emulation.

Kevin W McConeghyKwan HurIssa J DahabrehRong JiangLucy PandeyWalid F GelladPeter GlassmanChester B GoodDonald R MillerAndrew R ZulloStefan GravensteinFrancesca Cunningham

Published in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2024)

Vaccination against COVID-19 was associated with a lower but not statistically significantly different risk of death in the first 60 days. These results agree with prior scientific knowledge suggesting vaccination is safe with the potential for substantial health benefits.

Keyphrases

coronavirus disease
sars cov
healthcare
public health
clinical trial
mental health
study protocol
human health
phase iii
randomized controlled trial
respiratory syndrome coronavirus
risk assessment